Application of whole exome sequencing technology in fetuses with congenital structural abnormalities.
10.3760/cma.j.cn511374-20200923-00685
- Author:
Lushan LI
1
;
Fang FU
;
Ru LI
;
Qiuxia YU
;
Dan WANG
;
Tingying LEI
;
Qiong DENG
;
Wenwen ZHANG
;
Kun DU
;
Xin YANG
;
Jin HAN
;
Li ZHEN
;
Min PAN
;
Li'na ZHANG
;
Fucheng LI
;
Yongling ZHANG
;
Xiangyi JING
;
Dongzhi LI
;
Can LIAO
Author Information
1. Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623 China. canliao@hotmail.com.
- Publication Type:Journal Article
- MeSH:
Female;
Fetal Diseases;
Fetus/diagnostic imaging*;
Humans;
Pregnancy;
Prenatal Diagnosis;
Technology;
Ultrasonography, Prenatal;
Whole Exome Sequencing
- From:
Chinese Journal of Medical Genetics
2021;38(9):900-906
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the application value of whole exome sequencing technology in fetuses with congenital structural abnormalities.
METHODS:The chromosomal abnormalities of 1147 families were analyzed. According to the follow-up results, the data of fetuses with new phenotypes in late pregnancy or after birth were reanalyzed. Subgroups were divided according to the organs involved and whether single malformation or not. The gene regulatory network map was drawn by using string database and Cytoscape software. Fisher exact probability method was used to compare the difference of the diagnostic rate of pathogenic genes among the groups.
RESULTS:A total of 160 fetal cases received positive molecular diagnosed, involving 178 variant sites of 125 pathogenic genes, including 8 cases (4.9%, 8/163) by data reanalysis, and the overall positive diagnosis rate was 13.9%. Diagnostic rate was highest in the group of skeletal malformation (31.5%, 39/124) and lowest in that with thoracic malformation (0, 0/32). The gene clusters of fetal edema and intrauterine growth restriction were independent, and were not associated with the major structural malformations. The probability of each parent carrying the same recessive gene variant was 0.03 (39/1146) and 0.08 (4/53) with positive family history.
CONCLUSION:For fetuses with congenital structural abnormalities that are negative for conventional genetic tests, 13.9% of phenotypic associated pathogenic/likely pathogenic genetic variants can be detected by whole exome sequencing technology. Its application value for prenatal diagnosis varies in fetus with different organs involved. Reanalysis of sequencing data for cases with new phenotypes in late pregnancy or after birth can further improve the molecular diagnosis rate. Further investigations are needed to explore the related genetic mechanisms.
